低剂量胰岛素作为乳房手术抗瘢痕治疗:一项随机对照试验
一项随机、患者内、安慰剂对照试验纳入91例接受双侧美容乳房手术的患者,在乳房下皱襞切口内侧3 cm处注射低剂量胰岛素与安慰剂,于3、6、12个月用Manchester瘢痕量表评估瘢痕质量。12个月时胰岛素治疗侧瘢痕评分低于安慰剂侧(p=0.055);在瘢痕较重者中,胰岛素治疗侧瘢痕轮廓(p=0.048)与瘢痕扭曲(p=0.045)评分显著更低。结论认为皮下胰岛素注射可减少瘢痕外观,在瘢痕较重者中效果最明显,尚需进一步研究明确哪些受试者获益最大。
要点
- 91例双侧美容乳房手术患者行患者内随机对照,切口内侧3 cm注射低剂量胰岛素与安慰剂。
- 12个月时胰岛素治疗侧瘢痕评分低于安慰剂侧,p=0.055。
- 瘢痕较重者中胰岛素侧瘢痕轮廓p=0.048、瘢痕扭曲p=0.045显著更低。
核心结论
- 皮下胰岛素注射与本研究中安慰剂相比减少了瘢痕外观。
- 在瘢痕较重者中效果最明显,胰岛素在可能受较重瘢痕影响者中具有抗瘢痕治疗作用。
- 需要进一步研究以更精确地界定哪些受试者可能从该治疗中获益最大。
研究设计与样本
- 随机、患者内、安慰剂对照试验。
- 纳入91例接受双侧美容乳房手术的患者。
- 在乳房下皱襞切口内侧3 cm处注射低剂量胰岛素与安慰剂。
- 于3、6、12个月复查时用Manchester瘢痕量表评估瘢痕质量。
- 证据等级:治疗性,II级。
主要发现
- 12个月复查时整个队列中胰岛素治疗侧瘢痕评分低于安慰剂侧(p=0.055)。
- 瘢痕较重者亚组分析中,胰岛素治疗侧瘢痕轮廓评分中位数显著低于安慰剂侧(p=0.048)。
- 瘢痕较重者亚组分析中,胰岛素治疗侧瘢痕扭曲评分中位数显著低于安慰剂侧(p=0.045)。
临床怎么用
- 作者认为皮下胰岛素注射可减少瘢痕外观,在瘢痕较重者中效果最明显。
- 作者认为胰岛素在可能受较重瘢痕影响者中具有抗瘢痕治疗作用。
- 作者指出需要进一步研究以更精确地界定哪些受试者可能从该治疗中获益最大。
局限性
- 需要进一步研究以更精确地界定哪些受试者可能从该治疗中获益最大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of insulin in expediting wound healing is firmly established within the context of major trauma and burns; however, only limited clinical evidence exists as to its effects on scar formation. This study aims to build on previous laboratory work to examine the potential antiscarring properties of insulin in a clinical environment. METHODS: Ninety-one patients undergoing bilateral aesthetic breast operations were recruited to receive low-dose insulin and placebo injections to the medial 3 cm of their submammary incisions within the context of a randomized, intrapatient, placebo-controlled trial, and scar quality was assessed at 3-, 6-, and 12-month reviews using the Manchester Scar Scale. RESULTS: Across the cohort at 12-month review, the insulin-treated scars had lower scar scores (p = 0.055) compared with placebo. Subgroup analysis of individuals with heavier scars showed that median scar scores were significantly lower for the insulin-treated scars with regard to both scar contour (p = 0.048) and scar distortion (p = 0.045). CONCLUSIONS: Subcutaneous insulin injections reduced the appearance of scarring in this study compared with placebo. The greatest effect was seen in those participants who showed heavier scars and, as such, insulin has a role as an antiscarring therapy in individuals likely to be affected by heavier scarring. Further research is required to more precisely delineate which subjects may benefit most from this treatment. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
引用
- Hallam MJ, Pitt E, Thomas A, et al. Low-Dose Insulin as an Antiscarring Therapy in Breast Surgery: A Randomized Controlled Trial. Plast Reconstr Surg. 2018. PMID: 29240641. doi:10.1097/PRS.0000000000004199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。